BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16150403)

  • 1. Diagnosis and treatment of kidney disease.
    Cross J; Jayne D
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):785-98. PubMed ID: 16150403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.
    Lenz O; Fornoni A; Contreras G
    Drugs; 2005; 65(17):2429-36. PubMed ID: 16296869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lupus nephritis: up-to-date].
    Karras A
    Rev Med Interne; 2015 Feb; 36(2):98-106. PubMed ID: 25443980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
    van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
    Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical approach to lupus nephritis: recent advances.
    Molino C; Fabbian F; Longhini C
    Eur J Intern Med; 2009 Sep; 20(5):447-53. PubMed ID: 19712841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
    Pisoni CN; Sanchez FJ; Karim Y; Cuadrado MJ; D'Cruz DP; Abbs IC; Khamasta MA; Hughes GR
    J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe lupus nephritis: the new horizon.
    Chan TM
    Nat Rev Nephrol; 2015 Jan; 11(1):46-61. PubMed ID: 25421826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephritis as an initial diagnosis of lupus in Nigerian patients.
    Adelowo OO; Umeizudike T; Olaosebikan H; Awobusuyi JO
    Afr J Med Med Sci; 2014 Jun; 43(2):99-105. PubMed ID: 25474984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
    Urowitz MB; Ibañez D; Ali Y; Gladman DD
    J Rheumatol; 2007 Jul; 34(7):1491-6. PubMed ID: 17610320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
    Elliott JR; Manzi S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
    N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential therapies for proliferative lupus nephritis.
    Yee CS; Gordon C
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15190147
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.